Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Abbott Laboratories saw active trading and strong earnings, boosting its $231.28B market cap.
Institutional investors have been actively trading in Abbott Laboratories, with Chancellor Financial Group buying shares and Old North State Trust reducing its stake.
Meanwhile, Abbott reported a strong quarter with earnings per share of $1.09, slightly above expectations.
The company, which makes healthcare products, has a market cap of $231.28 billion and operates in four segments.
Analysts predict a "Moderate Buy" with a price target of $142.59.
12 Articles
Abbott Laboratories vio un comercio activo y fuertes ganancias, impulsando su capitalización de mercado de $ 231.28B.